| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.3M | +56.9% |
| Cost of Revenue | $19.5M | -11.1% |
| Gross Profit | $15.8M | +2857.4% |
| R&D Expense | $31.6M | -23.2% |
| SG&A Expense | $52.5M | +53.4% |
| Operating Income | -$68.3M | +8.7% |
| Interest Expense | $5.0M | -41.3% |
| Pre-tax Income | -$69.1M | +12.1% |
| Income Tax | $0 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.2M | -46.1% |
| Short-term Investments | $53.8M | — |
| Inventory | $6.7M | +51.6% |
| Current Assets | $117.5M | +28.5% |
| Total Assets | $126.3M | +25.7% |
| Current Liabilities | $24.3M | -37.3% |
| Long-term Debt | $35.6M | +2.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.1M | +2.2% |
| Investing Cash Flow | -$53.4M | -262.7% |
| Financing Cash Flow | $78.2M | +191.4% |
| — |
| Net Income | -$69.1M | +12.1% |
| EPS (Basic) | -$1.66 | -1283.3% |
| EPS (Diluted) | -$1.66 | -1283.3% |
| Total Liabilities |
| $65.2M |
| -17.8% |
| Stockholders' Equity | $61.0M | +468.7% |